JP2008512399A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512399A5
JP2008512399A5 JP2007530572A JP2007530572A JP2008512399A5 JP 2008512399 A5 JP2008512399 A5 JP 2008512399A5 JP 2007530572 A JP2007530572 A JP 2007530572A JP 2007530572 A JP2007530572 A JP 2007530572A JP 2008512399 A5 JP2008512399 A5 JP 2008512399A5
Authority
JP
Japan
Prior art keywords
enzyme
pharmaceutical composition
composition according
arginase
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512399A (ja
Filing date
Publication date
Priority claimed from CNA2004100768544A external-priority patent/CN1745847A/zh
Application filed filed Critical
Publication of JP2008512399A publication Critical patent/JP2008512399A/ja
Publication of JP2008512399A5 publication Critical patent/JP2008512399A5/ja
Pending legal-status Critical Current

Links

JP2007530572A 2004-09-08 2005-09-06 医薬組成物およびアルギナーゼを用いる肝炎の処置方法 Pending JP2008512399A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2004100768544A CN1745847A (zh) 2004-09-08 2004-09-08 用精氨酸酶治疗肝炎的药物组合物和方法
PCT/CN2005/001411 WO2006026915A1 (fr) 2004-09-08 2005-09-06 Composition pharmaceutique et methode de traitement de l'hepatite avec des arginases

Publications (2)

Publication Number Publication Date
JP2008512399A JP2008512399A (ja) 2008-04-24
JP2008512399A5 true JP2008512399A5 (enExample) 2008-10-02

Family

ID=36036072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530572A Pending JP2008512399A (ja) 2004-09-08 2005-09-06 医薬組成物およびアルギナーゼを用いる肝炎の処置方法

Country Status (6)

Country Link
US (1) US20080299638A1 (enExample)
EP (1) EP1803465A4 (enExample)
JP (1) JP2008512399A (enExample)
KR (1) KR20070100875A (enExample)
CN (1) CN1745847A (enExample)
WO (1) WO2006026915A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350273B1 (en) 2008-10-31 2016-04-06 AERase, Inc. Compositions of engineered human arginases and methods for treating cancer
AU2010242422B2 (en) * 2009-03-26 2014-12-04 The Hong Kong Polytechnic University Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
CN103184208B (zh) 2011-12-27 2015-09-16 拜奥生物科技(上海)有限公司 人精氨酸酶和定点聚乙二醇化人精氨酸酶及其应用
ES2897635T3 (es) 2014-04-29 2022-03-02 Bio Cancer Treat International Ltd Métodos y composiciones para modular el sistema inmunológico con la arginasa I
SMT202200157T1 (it) 2016-08-08 2022-05-12 Aerase Inc Composizioni e procedimenti per trattare il cancro con deplezione di arginina e agenti immuno-oncologici
MX2020005933A (es) 2017-12-05 2021-01-15 Aerase Inc Metodo y composicion para tratar la deficiencia de arginasa 1.
EP3866837A1 (en) 2018-10-19 2021-08-25 AERase, Inc. Arginine depletion therapy for treatment of gamt deficiency
JP2022545738A (ja) 2019-08-30 2022-10-28 アエグリア バイオセラピューティクス, インク. ヒト組換えアルギナーゼ1の製造方法およびその使用
CA3180529A1 (en) * 2020-04-17 2021-10-21 Bio-Cancer Treatment International Limited Methods of treating viral infections using arginase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059127C (zh) * 1995-07-19 2000-12-06 郝文学 治疗肝病的药物“疏肝酶”的制法
US5780286A (en) * 1996-03-14 1998-07-14 Smithkline Beecham Corporation Arginase II
US5851985A (en) * 1996-08-16 1998-12-22 Tepic; Slobodan Treatment of tumors by arginine deprivation
US6183738B1 (en) * 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
HK1053577A2 (en) * 2002-06-20 2003-10-10 Bio-Cancer Treatment International Limited Pharmaceutical composition and method of treatment of human malignanices with arginine deprivation
AU2003250371B2 (en) * 2002-06-20 2009-01-29 Bio-Cancer Treatment International Limited Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation

Similar Documents

Publication Publication Date Title
ES2303361T3 (es) Conjugados de interferon-alfa-polimero con actividad biologica potenciada y procedimientos de preparacion de los mismos.
EP0981607B1 (en) Modified arginine deiminase
JP5746137B2 (ja) アルギナーゼの部位指定的ペグ化並びにその抗がん剤及び抗ウイルス剤としての使用
CA2203480C (en) Interferon conjugates
ES2207830T3 (es) Conjugados de polietilenglicol-interferon alfa para la terapia de infecciones.
JP2012521201A5 (enExample)
JP2008512399A5 (enExample)
EP1337630A2 (en) Modified arginine deiminase
CN103228792A (zh) PEG-干扰素λ1结合物
CN1655812A (zh) 抗微生物聚合物轭合物
CN102453089B (zh) 重组集成干扰素变异体聚乙二醇偶联物的制备和应用
RU2005101076A (ru) Фармацевтический препарат и способ лечения злокачественных опухолей у человека с помощью аргининовой депривации
JP5613050B2 (ja) タンパク質−高分子結合体
Lollo et al. Gene therapy strategies for the treatment of chronic viral hepatitis
JP5798628B2 (ja) ウシ顆粒球コロニー刺激因子のための製剤およびその変異体
JP5639585B2 (ja) ペプチド−ポリマー共役体
CN102724980B (zh) 蛋白-聚合物偶联物的治疗用途
Srichana et al. Polyethylene glycol in glinical application and PEGylated drugs
CN104136038A (zh) 体腔积液抑制剂